Aspirin for cerebral transient ischemic attacks or minor ischemic strokes

Gudrun Boysen, Palle Petersen, te Wen Chang, J. Van Gijn, A. Algra, P. J. Koudstaal, L. J. Kappelle, J. C. Van Latum

Research output: Contribution to journalLetterAcademicpeer-review

1 Citation (Scopus)

Abstract

To the Editor: The Dutch TIA Trial Study Group (Oct. 31 issue)1 has presented the results of a randomized, controlled study comparing the effects of two different doses of aspirin in patients with transient ischemic attacks or minor ischemic stroke. There was no significant difference in the occurrence of the combined end point of stroke, death from vascular causes, and acute myocardial infarction between the patients taking 30 mg of aspirin daily and those taking 283 mg. The authors concluded that the 30-mg dose was no less effective in preventing vascular events than the 283-mg dose. A problem with this.

Original languageEnglish
Pages (from-to)1288-1289
Number of pages2
JournalNew England Journal of Medicine
Volume326
Issue number19
DOIs
Publication statusPublished - 7 May 1992

Fingerprint

Dive into the research topics of 'Aspirin for cerebral transient ischemic attacks or minor ischemic strokes'. Together they form a unique fingerprint.

Cite this